“Aprepitant, a Novel Neurokinin-1 Receptor Antagonist in Management of Chemotherapy Induces Nausea Vomiting (CINV) in Cancer Patients”. International Journal of Research in Clinical and Hospital Pharmacy 2, no. 1 (September 14, 2019): 1–4. Accessed April 3, 2026. https://www.rubatosis.org/journals/index.php/ijrhcp/article/view/144.